- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global Premature Ejaculation Treatment market size was valued at USD 2946.9 million in 2022 and is forecast to a readjusted size of USD 5319.8 million by 2029 with a CAGR of 8.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Premature Ejaculation Treatment includes Pfizer, Bayer, Menarini, Lilly and Johnson & Johnson, etc. Global top 5 companies hold a share over 44%.
This report is a detailed and comprehensive analysis for global Premature Ejaculation Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Premature Ejaculation Treatment market size and forecasts, in consumption value ($ Million), sales quantity (Boxs), and average selling prices (Yuan/Box), 2018-2029
Global Premature Ejaculation Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Boxs), and average selling prices (Yuan/Box), 2018-2029
Global Premature Ejaculation Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Boxs), and average selling prices (Yuan/Box), 2018-2029
Global Premature Ejaculation Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (Boxs), and ASP (Yuan/Box), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Premature Ejaculation Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Premature Ejaculation Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bayer, Menarini, Lilly and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Premature Ejaculation Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antidepressants (SSRIs)
Type 5 Phosphodiesterase Inhibitor
Local Anesthetics
Traditional Chinese Medicine
Ethnic Medicine
Market segment by Application
Human Medicine
Veterinary Drugs
Major players covered
Pfizer
Bayer
Menarini
Lilly
Johnson & Johnson
GlaxoSmithKline
Hotan Uighur Pharmaceutical
Sichuan Kelun Pharmaceutical
Guangdong T&K Pharmaceutical Factory
Beijing Tongrentang
Tai Chi Group
Guangzhou Baiyunshan Pharmaceutical
Jiangxi Huiren Pharmaceutical
Jiuzhitang
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Premature Ejaculation Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Premature Ejaculation Treatment, with price, sales, revenue and global market share of Premature Ejaculation Treatment from 2018 to 2023.
Chapter 3, the Premature Ejaculation Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Premature Ejaculation Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Premature Ejaculation Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Premature Ejaculation Treatment.
Chapter 14 and 15, to describe Premature Ejaculation Treatment sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Premature Ejaculation Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Premature Ejaculation Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Antidepressants (SSRIs)
1.3.3 Type 5 Phosphodiesterase Inhibitor
1.3.4 Local Anesthetics
1.3.5 Traditional Chinese Medicine
1.3.6 Ethnic Medicine
1.4 Market Analysis by Application
1.4.1 Overview: Global Premature Ejaculation Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Human Medicine
1.4.3 Veterinary Drugs
1.5 Global Premature Ejaculation Treatment Market Size & Forecast
1.5.1 Global Premature Ejaculation Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Premature Ejaculation Treatment Sales Quantity (2018-2029)
1.5.3 Global Premature Ejaculation Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Premature Ejaculation Treatment Product and Services
2.1.4 Pfizer Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Premature Ejaculation Treatment Product and Services
2.2.4 Bayer Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer Recent Developments/Updates
2.3 Menarini
2.3.1 Menarini Details
2.3.2 Menarini Major Business
2.3.3 Menarini Premature Ejaculation Treatment Product and Services
2.3.4 Menarini Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Menarini Recent Developments/Updates
2.4 Lilly
2.4.1 Lilly Details
2.4.2 Lilly Major Business
2.4.3 Lilly Premature Ejaculation Treatment Product and Services
2.4.4 Lilly Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lilly Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Premature Ejaculation Treatment Product and Services
2.5.4 Johnson & Johnson Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Premature Ejaculation Treatment Product and Services
2.6.4 GlaxoSmithKline Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GlaxoSmithKline Recent Developments/Updates
2.7 Hotan Uighur Pharmaceutical
2.7.1 Hotan Uighur Pharmaceutical Details
2.7.2 Hotan Uighur Pharmaceutical Major Business
2.7.3 Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Product and Services
2.7.4 Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hotan Uighur Pharmaceutical Recent Developments/Updates
2.8 Sichuan Kelun Pharmaceutical
2.8.1 Sichuan Kelun Pharmaceutical Details
2.8.2 Sichuan Kelun Pharmaceutical Major Business
2.8.3 Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Product and Services
2.8.4 Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
2.9 Guangdong T&K Pharmaceutical Factory
2.9.1 Guangdong T&K Pharmaceutical Factory Details
2.9.2 Guangdong T&K Pharmaceutical Factory Major Business
2.9.3 Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Product and Services
2.9.4 Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guangdong T&K Pharmaceutical Factory Recent Developments/Updates
2.10 Beijing Tongrentang
2.10.1 Beijing Tongrentang Details
2.10.2 Beijing Tongrentang Major Business
2.10.3 Beijing Tongrentang Premature Ejaculation Treatment Product and Services
2.10.4 Beijing Tongrentang Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Beijing Tongrentang Recent Developments/Updates
2.11 Tai Chi Group
2.11.1 Tai Chi Group Details
2.11.2 Tai Chi Group Major Business
2.11.3 Tai Chi Group Premature Ejaculation Treatment Product and Services
2.11.4 Tai Chi Group Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tai Chi Group Recent Developments/Updates
2.12 Guangzhou Baiyunshan Pharmaceutical
2.12.1 Guangzhou Baiyunshan Pharmaceutical Details
2.12.2 Guangzhou Baiyunshan Pharmaceutical Major Business
2.12.3 Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Product and Services
2.12.4 Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
2.13 Jiangxi Huiren Pharmaceutical
2.13.1 Jiangxi Huiren Pharmaceutical Details
2.13.2 Jiangxi Huiren Pharmaceutical Major Business
2.13.3 Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Product and Services
2.13.4 Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jiangxi Huiren Pharmaceutical Recent Developments/Updates
2.14 Jiuzhitang
2.14.1 Jiuzhitang Details
2.14.2 Jiuzhitang Major Business
2.14.3 Jiuzhitang Premature Ejaculation Treatment Product and Services
2.14.4 Jiuzhitang Premature Ejaculation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Jiuzhitang Recent Developments/Updates
3 Competitive Environment: Premature Ejaculation Treatment by Manufacturer
3.1 Global Premature Ejaculation Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Premature Ejaculation Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Premature Ejaculation Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Premature Ejaculation Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Premature Ejaculation Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Premature Ejaculation Treatment Manufacturer Market Share in 2022
3.5 Premature Ejaculation Treatment Market: Overall Company Footprint Analysis
3.5.1 Premature Ejaculation Treatment Market: Region Footprint
3.5.2 Premature Ejaculation Treatment Market: Company Product Type Footprint
3.5.3 Premature Ejaculation Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Premature Ejaculation Treatment Market Size by Region
4.1.1 Global Premature Ejaculation Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Premature Ejaculation Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Premature Ejaculation Treatment Average Price by Region (2018-2029)
4.2 North America Premature Ejaculation Treatment Consumption Value (2018-2029)
4.3 Europe Premature Ejaculation Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Premature Ejaculation Treatment Consumption Value (2018-2029)
4.5 South America Premature Ejaculation Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Premature Ejaculation Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Premature Ejaculation Treatment Sales Quantity by Type (2018-2029)
5.2 Global Premature Ejaculation Treatment Consumption Value by Type (2018-2029)
5.3 Global Premature Ejaculation Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Premature Ejaculation Treatment Sales Quantity by Application (2018-2029)
6.2 Global Premature Ejaculation Treatment Consumption Value by Application (2018-2029)
6.3 Global Premature Ejaculation Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Premature Ejaculation Treatment Sales Quantity by Type (2018-2029)
7.2 North America Premature Ejaculation Treatment Sales Quantity by Application (2018-2029)
7.3 North America Premature Ejaculation Treatment Market Size by Country
7.3.1 North America Premature Ejaculation Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Premature Ejaculation Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Premature Ejaculation Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Premature Ejaculation Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Premature Ejaculation Treatment Market Size by Country
8.3.1 Europe Premature Ejaculation Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Premature Ejaculation Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Region
9.3.1 Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Premature Ejaculation Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Premature Ejaculation Treatment Sales Quantity by Type (2018-2029)
10.2 South America Premature Ejaculation Treatment Sales Quantity by Application (2018-2029)
10.3 South America Premature Ejaculation Treatment Market Size by Country
10.3.1 South America Premature Ejaculation Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Premature Ejaculation Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Country
11.3.1 Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Premature Ejaculation Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Premature Ejaculation Treatment Market Drivers
12.2 Premature Ejaculation Treatment Market Restraints
12.3 Premature Ejaculation Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Premature Ejaculation Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Premature Ejaculation Treatment
13.3 Premature Ejaculation Treatment Production Process
13.4 Premature Ejaculation Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Premature Ejaculation Treatment Typical Distributors
14.3 Premature Ejaculation Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Premature Ejaculation Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Premature Ejaculation Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Premature Ejaculation Treatment Product and Services
Table 6. Pfizer Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Premature Ejaculation Treatment Product and Services
Table 11. Bayer Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bayer Recent Developments/Updates
Table 13. Menarini Basic Information, Manufacturing Base and Competitors
Table 14. Menarini Major Business
Table 15. Menarini Premature Ejaculation Treatment Product and Services
Table 16. Menarini Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Menarini Recent Developments/Updates
Table 18. Lilly Basic Information, Manufacturing Base and Competitors
Table 19. Lilly Major Business
Table 20. Lilly Premature Ejaculation Treatment Product and Services
Table 21. Lilly Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lilly Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Premature Ejaculation Treatment Product and Services
Table 26. Johnson & Johnson Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Major Business
Table 30. GlaxoSmithKline Premature Ejaculation Treatment Product and Services
Table 31. GlaxoSmithKline Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GlaxoSmithKline Recent Developments/Updates
Table 33. Hotan Uighur Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Hotan Uighur Pharmaceutical Major Business
Table 35. Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Product and Services
Table 36. Hotan Uighur Pharmaceutical Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hotan Uighur Pharmaceutical Recent Developments/Updates
Table 38. Sichuan Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sichuan Kelun Pharmaceutical Major Business
Table 40. Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Product and Services
Table 41. Sichuan Kelun Pharmaceutical Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 43. Guangdong T&K Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 44. Guangdong T&K Pharmaceutical Factory Major Business
Table 45. Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Product and Services
Table 46. Guangdong T&K Pharmaceutical Factory Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Guangdong T&K Pharmaceutical Factory Recent Developments/Updates
Table 48. Beijing Tongrentang Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Tongrentang Major Business
Table 50. Beijing Tongrentang Premature Ejaculation Treatment Product and Services
Table 51. Beijing Tongrentang Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Beijing Tongrentang Recent Developments/Updates
Table 53. Tai Chi Group Basic Information, Manufacturing Base and Competitors
Table 54. Tai Chi Group Major Business
Table 55. Tai Chi Group Premature Ejaculation Treatment Product and Services
Table 56. Tai Chi Group Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tai Chi Group Recent Developments/Updates
Table 58. Guangzhou Baiyunshan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Guangzhou Baiyunshan Pharmaceutical Major Business
Table 60. Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Product and Services
Table 61. Guangzhou Baiyunshan Pharmaceutical Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 63. Jiangxi Huiren Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Jiangxi Huiren Pharmaceutical Major Business
Table 65. Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Product and Services
Table 66. Jiangxi Huiren Pharmaceutical Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Jiangxi Huiren Pharmaceutical Recent Developments/Updates
Table 68. Jiuzhitang Basic Information, Manufacturing Base and Competitors
Table 69. Jiuzhitang Major Business
Table 70. Jiuzhitang Premature Ejaculation Treatment Product and Services
Table 71. Jiuzhitang Premature Ejaculation Treatment Sales Quantity (Boxs), Average Price (Yuan/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Jiuzhitang Recent Developments/Updates
Table 73. Global Premature Ejaculation Treatment Sales Quantity by Manufacturer (2018-2023) & (Boxs)
Table 74. Global Premature Ejaculation Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Premature Ejaculation Treatment Average Price by Manufacturer (2018-2023) & (Yuan/Box)
Table 76. Market Position of Manufacturers in Premature Ejaculation Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Premature Ejaculation Treatment Production Site of Key Manufacturer
Table 78. Premature Ejaculation Treatment Market: Company Product Type Footprint
Table 79. Premature Ejaculation Treatment Market: Company Product Application Footprint
Table 80. Premature Ejaculation Treatment New Market Entrants and Barriers to Market Entry
Table 81. Premature Ejaculation Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Premature Ejaculation Treatment Sales Quantity by Region (2018-2023) & (Boxs)
Table 83. Global Premature Ejaculation Treatment Sales Quantity by Region (2024-2029) & (Boxs)
Table 84. Global Premature Ejaculation Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Premature Ejaculation Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Premature Ejaculation Treatment Average Price by Region (2018-2023) & (Yuan/Box)
Table 87. Global Premature Ejaculation Treatment Average Price by Region (2024-2029) & (Yuan/Box)
Table 88. Global Premature Ejaculation Treatment Sales Quantity by Type (2018-2023) & (Boxs)
Table 89. Global Premature Ejaculation Treatment Sales Quantity by Type (2024-2029) & (Boxs)
Table 90. Global Premature Ejaculation Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Premature Ejaculation Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Premature Ejaculation Treatment Average Price by Type (2018-2023) & (Yuan/Box)
Table 93. Global Premature Ejaculation Treatment Average Price by Type (2024-2029) & (Yuan/Box)
Table 94. Global Premature Ejaculation Treatment Sales Quantity by Application (2018-2023) & (Boxs)
Table 95. Global Premature Ejaculation Treatment Sales Quantity by Application (2024-2029) & (Boxs)
Table 96. Global Premature Ejaculation Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Premature Ejaculation Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Premature Ejaculation Treatment Average Price by Application (2018-2023) & (Yuan/Box)
Table 99. Global Premature Ejaculation Treatment Average Price by Application (2024-2029) & (Yuan/Box)
Table 100. North America Premature Ejaculation Treatment Sales Quantity by Type (2018-2023) & (Boxs)
Table 101. North America Premature Ejaculation Treatment Sales Quantity by Type (2024-2029) & (Boxs)
Table 102. North America Premature Ejaculation Treatment Sales Quantity by Application (2018-2023) & (Boxs)
Table 103. North America Premature Ejaculation Treatment Sales Quantity by Application (2024-2029) & (Boxs)
Table 104. North America Premature Ejaculation Treatment Sales Quantity by Country (2018-2023) & (Boxs)
Table 105. North America Premature Ejaculation Treatment Sales Quantity by Country (2024-2029) & (Boxs)
Table 106. North America Premature Ejaculation Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Premature Ejaculation Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Premature Ejaculation Treatment Sales Quantity by Type (2018-2023) & (Boxs)
Table 109. Europe Premature Ejaculation Treatment Sales Quantity by Type (2024-2029) & (Boxs)
Table 110. Europe Premature Ejaculation Treatment Sales Quantity by Application (2018-2023) & (Boxs)
Table 111. Europe Premature Ejaculation Treatment Sales Quantity by Application (2024-2029) & (Boxs)
Table 112. Europe Premature Ejaculation Treatment Sales Quantity by Country (2018-2023) & (Boxs)
Table 113. Europe Premature Ejaculation Treatment Sales Quantity by Country (2024-2029) & (Boxs)
Table 114. Europe Premature Ejaculation Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Premature Ejaculation Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Type (2018-2023) & (Boxs)
Table 117. Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Type (2024-2029) & (Boxs)
Table 118. Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Application (2018-2023) & (Boxs)
Table 119. Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Application (2024-2029) & (Boxs)
Table 120. Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Region (2018-2023) & (Boxs)
Table 121. Asia-Pacific Premature Ejaculation Treatment Sales Quantity by Region (2024-2029) & (Boxs)
Table 122. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Premature Ejaculation Treatment Sales Quantity by Type (2018-2023) & (Boxs)
Table 125. South America Premature Ejaculation Treatment Sales Quantity by Type (2024-2029) & (Boxs)
Table 126. South America Premature Ejaculation Treatment Sales Quantity by Application (2018-2023) & (Boxs)
Table 127. South America Premature Ejaculation Treatment Sales Quantity by Application (2024-2029) & (Boxs)
Table 128. South America Premature Ejaculation Treatment Sales Quantity by Country (2018-2023) & (Boxs)
Table 129. South America Premature Ejaculation Treatment Sales Quantity by Country (2024-2029) & (Boxs)
Table 130. South America Premature Ejaculation Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Premature Ejaculation Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Type (2018-2023) & (Boxs)
Table 133. Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Type (2024-2029) & (Boxs)
Table 134. Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Application (2018-2023) & (Boxs)
Table 135. Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Application (2024-2029) & (Boxs)
Table 136. Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Region (2018-2023) & (Boxs)
Table 137. Middle East & Africa Premature Ejaculation Treatment Sales Quantity by Region (2024-2029) & (Boxs)
Table 138. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Premature Ejaculation Treatment Raw Material
Table 141. Key Manufacturers of Premature Ejaculation Treatment Raw Materials
Table 142. Premature Ejaculation Treatment Typical Distributors
Table 143. Premature Ejaculation Treatment Typical Customers
List of Figures
Figure 1. Premature Ejaculation Treatment Picture
Figure 2. Global Premature Ejaculation Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Premature Ejaculation Treatment Consumption Value Market Share by Type in 2022
Figure 4. Antidepressants (SSRIs) Examples
Figure 5. Type 5 Phosphodiesterase Inhibitor Examples
Figure 6. Local Anesthetics Examples
Figure 7. Traditional Chinese Medicine Examples
Figure 8. Ethnic Medicine Examples
Figure 9. Global Premature Ejaculation Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Premature Ejaculation Treatment Consumption Value Market Share by Application in 2022
Figure 11. Human Medicine Examples
Figure 12. Veterinary Drugs Examples
Figure 13. Global Premature Ejaculation Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Premature Ejaculation Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Premature Ejaculation Treatment Sales Quantity (2018-2029) & (Boxs)
Figure 16. Global Premature Ejaculation Treatment Average Price (2018-2029) & (Yuan/Box)
Figure 17. Global Premature Ejaculation Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Premature Ejaculation Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Premature Ejaculation Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Premature Ejaculation Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Premature Ejaculation Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Premature Ejaculation Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Premature Ejaculation Treatment Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Premature Ejaculation Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Premature Ejaculation Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Premature Ejaculation Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Premature Ejaculation Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Premature Ejaculation Treatment Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Premature Ejaculation Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Premature Ejaculation Treatment Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Premature Ejaculation Treatment Average Price by Type (2018-2029) & (Yuan/Box)
Figure 32. Global Premature Ejaculation Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Premature Ejaculation Treatment Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Premature Ejaculation Treatment Average Price by Application (2018-2029) & (Yuan/Box)
Figure 35. North America Premature Ejaculation Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Premature Ejaculation Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Premature Ejaculation Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Premature Ejaculation Treatment Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Premature Ejaculation Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Premature Ejaculation Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Premature Ejaculation Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Premature Ejaculation Treatment Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Premature Ejaculation Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Premature Ejaculation Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Premature Ejaculation Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Premature Ejaculation Treatment Consumption Value Market Share by Region (2018-2029)
Figure 55. China Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Premature Ejaculation Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Premature Ejaculation Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Premature Ejaculation Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Premature Ejaculation Treatment Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Premature Ejaculation Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Premature Ejaculation Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Premature Ejaculation Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Premature Ejaculation Treatment Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Premature Ejaculation Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Premature Ejaculation Treatment Market Drivers
Figure 76. Premature Ejaculation Treatment Market Restraints
Figure 77. Premature Ejaculation Treatment Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Premature Ejaculation Treatment in 2022
Figure 80. Manufacturing Process Analysis of Premature Ejaculation Treatment
Figure 81. Premature Ejaculation Treatment Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
